47 results about "Transcutaneous stimulation" patented technology

The invention relates to a device for transdermal stimulation of a nerve of the human body, which device comprises at least one stimulation electrode and at least one reference electrode for transdermal nerve stimulation, the at least one stimulation electrode and the at least one reference electrode being connected to a control unit and being able to be supplied with an electrical current from the latter, and the at least one stimulation electrode and the at least one reference electrode being arranged in or on a housing which is designed to be fitted on or in the human ear. The invention further relates to a method for the transdermal stimulation of a nerve of the human body in particular of a part of the vagus nerve by applying an electrical stimulus via at least one stimulation electrode and at least one reference electrode, at least one of which is placed in contact with the skin surface of the inner face of the Tragus of the human ear. The invention further relates to transdermal stimulation of a part of the vagus nerve by electrical stimulation via the inner face of the Tragus of the human ear for the treatment and/or supportive therapy of a plurality of pathological conditions.

A novel method and system for performing transcutaneous magnetic stimulation is disclosed herein. In the method, a first magnetic field is generated using a first magnetic stimulation device for transcutaneously stimulating a treatment area, and a second magnetic field for transcutaneously stimulating the treatment area is generated by a second magnetic stimulation device. In addition, a novel method and system for reducing discomfort caused by transcutaneous magnetic stimulation is disclosed herein. In the method, a first magnetic field is created at a first and second location using a first magnetic stimulation device. The first magnetic field causes magnetic stimulation at the first and second locations. A second magnetic field is created at the second location using a second magnetic stimulation device, thereby reducing stimulation at the second location.

A percutaneous neurological stimulation lead has at least a first lead body and a second lead body that interlock during implantation using interlocking elements. The first lead body has at least one first detail on the first lead body distal end that is configured to engage at least one second detail on the second lead body distal end that is complimentary to the first detail to mechanically couple the first lead body to the second lead body. Many embodiments of the implantable neurological stimulation lead with interlocking elements and its methods of operation are possible.

The apparatus for transcutaneous stimulation or transcutaneous measurement of a parameter is a device which fits wholly within the pinna (external ear) of the vertebrate. In order to fit completely within the pinna, the housing is C-shaped and from each end of the housing is a curved section which has a spring action that holds the apparatus inside the ear. This apparatus has a compact design which allows for nerve stimulation in a particularly efficient, ergonomically favorable and easy manipulation for the patient.

Electrical-stimulation device with gel-dispensing kit, and a method of making and using the parts of the kit. A convenient and easy-to-use system to provide an electrically conductive path from a transcutaneous electrical nerve stimulation (TENS) device to the skin surface of a patient to supply transcutaneous stimulation, even through hair. The invention provides improved prevention and treatment for headache, depression, alertness, attention deficit hyperactivity disorder (ADHD), epilepsy, anxiety, post-traumatic stress disorder (PTSD), and behavioral and/or other disorders. Some embodiments provide a headache-treatment system that includes an electrode base shaped to conform to a back of a human head; a TENS having projecting spring electrodes each connected to the electrode base; means for holding an electrically conductive gel in a plurality of sealed pockets; and means for unsealing the means for holding the gel and applying the gel substantially simultaneously to the projecting spring electrodes.

An implantable neurological stimulation lead has a lead carrier with an attachment detail for coupling to a first lead body first distal end and an electrode shield to insulate a portion of the electrode. The first lead body has an outer body, a first distal end, and a first proximal end. The first lead body includes at least one electrode carried on the first distal end, at least one electrical connector carried on the first proximal end, and at least one conductor electrically connecting the electrode to the electrical connector and insulated by the lead body. The lead carrier has many embodiments and methods of operation.

The present invention relates to a portable device for alleviating menstrual pain through transcutaneous electrical nerve stimulation (TENS) and thermal stimulation. More particularly, the present invention relates to a portable device for alleviating menstrual pain by applying transcutaneous electrical nerve stimulation to the abdominal and back area of a user through the use of a planar heart embedded in the stimulating electrode pad. The stimulating electrode pad is a patch type one which is attachable/detachable to/from any body part with menstrual pain. The portable device for alleviating menstrual pain in the public area of the user according to the present invention comprises, a menstrual pain alleviating unit and a main body unit. The menstrual pain alleviating unit includes a transcutaneous stimulating electrode pad portion provided with a transcutaneous stimulating electrode to apply transcutaneous stimulation to the abdominal or back area of the user, and a planar heater portion provided with a planar hater to apply thermal stimulation to the abdomen of the user. The main body unit includes a power portion for supplying power to the menstrual pain alleviating unit, and an operation processing portion for generating a transcutaneous stimulating electrode control signal for controlling the transcutaneous stimulating electrode pad portion and a planar heater control signal for controlling the planar heater portion. The menstrual pain alleviating unit further includes a temperature sensing portion provided with a temperature sensor mounted on the planar heater portion to sense the temperature of the planar heater portion, and an A/D converting portion for converting the signal output from the temperature sensing portion into a digital signal.

A method of identifying a location for applying a stimulation therapy to treat a patient includes stimulating a first body region of the patient transcutaneously via a stimulus generator. The body region contains a first portion of a nerve that has an elongate shape. In response to the stimulating, action potentials received from a second portion of the nerve are monitored over a period of time. The second portion of the nerve is in a second body region of the patient that is located remotely from the first body region. Based on the monitoring, an optimized location of the second portion of the nerve is determined for applying the stimulation therapy to treat the first body region.

A device for transcutaneous electrical stimulation is provided. The device comprises circuitry configured to generate transcutaneous stimulation signals. The device also comprises a first signal output component for electrically connecting to a first electrode connector to deliver generated transcutaneous stimulation signals. The first signal output component comprises a first four-pole electrical connector part. The device further comprises a second signal output component for electrically connecting to a second electrode connector to deliver generated transcutaneous stimulation signals. The second signal output component comprises a second four-pole electrical connector part. The device further comprises a controller to selectively control output of the stimulation signals to selected pairs of poles across the first and second four-pole electrical connector parts. Each selected pair of poles comprises one pole from the first four-pole electrical connector part and one pole from the second four-pole electrical connector part.

An apparatus to stimulate resonant frequencies of mammals, including humans, through transcutaneously applied bipolar micro-current therapeutic frequencies eXclusive OR (XOR) modulated over a variable duty cycle carrier square wave. A Fibonacci number clocked stored-program microcontroller generates a variable duty cycle higher frequency pulse width modulation (PWM) carrier square wave output which is XOR modulated with a lower therapeutic frequency square wave output to control an H-Bridge driver capacitive coupled to an isolation transformer. The preferred embodiment supports one or more user inputs and displaying program and operational information on a suitable display. Further, using an H-Bridge to drive an inductive load with bi-polar pulses creates scalar waves when the H-Bridge's output is switched from one polarity to the opposite each time the therapeutic low frequency square wave output XOR modulates the higher frequency PWM square wave.

The invention relates to an electrode arrangement (1) to be attached on and/or in the ear (2) of a human, wherein the electrode arrangement (1) is designed to exert a transcutaneous electric stimulation stimulus onto the surface (3, 4) of the ear (2) and wherein the electrode arrangement (1) has at least one stimulation electrode (5) and at least one reference electrode (6). In order to achieve improved transcutaneous stimulation of the vagus nerve in particular, the invention provides for the at least one stimulation electrode (5) to contact the surface (3) of the ear (2) via a first contact surface (A1) and for the at least one reference electrode (6) to contact the surface (4) of the ear (2) via a second contact surface (A2), wherein the second contact surface (A2) is at least three times the size of the first contact surface (A1).

A method of treating a waste evacuation dysfunction comprising administering transcutaneous electrical stimulation (TES) to at least one lower pelvic and/or sacral region for a specific treatment regimens. Also disclosed is a system for configuring a stimulation device to deliver transcutaneous electrical stimulation (TES) the system comprising: a computing device storing or having access to a plurality or TES settings and comprising a user interface to enable authorised selection of at least on of the TES settings for provision of TES by the stimulation device according to the at least one selected TES setting and the stimulation device communicatively coupled to the computing device to receive and store the selected at least one TES setting the stimulation device being of a size to be readily carried on a body and configured to selectively provide current to external electrode according to the one TES setting.

Systems and methods for treating symptoms of an inflammatory gastrointestinal disease in a patient with transcutaneous stimulation of a peripheral nerve are disclosed. The method can include any number of positioning a first peripheral nerve effector on the patient's skin to stimulate the peripheral nerve of the patient, delivering a first electrical nerve stimulation signal transcutaneously to the peripheral nerve through the first peripheral nerve effector, and modifying at least one brain or spinal cord autonomic feedback loop relating to release of neurotransmitters from the autonomic nervous system that modulate synthesis of inflammatory biomarkers and reduce inflammation relating to the inflammatory gastrointestinal disease.

An apparatus for transcutaneous stimulation comprising: a pulse generator operative to generate repetitive pulses exhibiting a pulse width of 25-60 microseconds, a consistent pulse rise time of no more than 5% of the pulse width and an inter-pulse interval of between 0.1 and 3 milliseconds; an intra-group modulator producing modulated pulses exhibiting an amplitude of between 50% and 100% of a maximum modulated pulse amplitude in a generally increasing manner, the modulated pulses defining a group of pulses, the intra-group modulator being further operative to modulate the pulses to exhibit an amplitude of no more than 25% of the maximum modulated pulse amplitude for a predetermined time period between successive groups of pulses thereby creating a pulse train; and an output modulator modulating the pulse train to produce output pulses exhibiting an amplitude of between 50% and 100% of a maximum according to a predetermined repetitive waveform.

A system and method for the transcutaneous stimulation of various nerves such as the phrenic, hypoglossal, and vagal nerves is provided. The stimulation elicits a corresponding muscle response without reported pain.

Systems and methods for implementation of a disposable miniaturized implant for treatment of Post-Operative Ileums (POI),a miniaturized implant for treating chronic GI dysmotility (e.g., dysphagia, gastroesophageal reflux disease (GERD), nausea, functional dyspepsia, blockage of transit, and gastroparesis, inflammatory bowel disease) and obesity, by providing electrical stimulation to the part of bowel going through surgery to expedite the healing process while recording the smooth muscle activities simultaneously, or providing stimulation on a treatment location of the GI tract or the branch of the vagus nerve. Systems and methods are also provided for non-invasive, transcutaneous stimulation of anatomy within the abdomen of the patient.

Methods, apparatus, and systems are disclosed for optimization techniques and a realistic 3D model to design optimal parameters for transcutaneous stimulation to achieve focalized stimulation of a target tissue such as the spinal cord, brain or other internal organ. The methods, apparatus, and systems include generation of a 3D model from a CT/MRI image, as well as an optimization algorithm that enables stimulation of any target location (e.g., on the dorsal root, or on the dorsal column) with any orientation at high precision.

The invention discloses a transcutaneous stimulator and a method for enhancing the fine movement level of human hands thereof. The transcutaneous stimulator comprises an upper PC, a singlechip, a display module, an A/D converter, a D/A converter, a signal regulation circuit, a noise stimulation device and a feedback circuit, wherein the signal regulation circuit comprises an amplitude regulation circuit, and the feedback circuit comprises an RMS/DC conversion circuit; the PC, the display module, the A/D converter and the D/A converter are electrically connected with the singlechip respectively, the RMS/DC conversion circuit of the feedback circuit is electrically connected with the A/D converter, the signal regulation circuit is electrically connected with the D/A converter and the noise stimulation device respectively. The invention has the advantages that the generated white noise waveform is converted into the electrical noise stimulus or the mechanical vibration noise stimulus to satisfy the condition for a human body to generate a random resonance phenomenon, and the appropriate intensity electrical noise or the appropriate intensity vibration noise stimulus is given to handsto reduce the limens of the hands feeling, thereby enhancing the fine movement level of the hands.

Transdermal electrical stimulation (TES) applicators that are wearable and configured to attached to a subject's pinna (ear) and adapted to apply TES to modulate the subject's cognitive and/or physiological state. These apparatuses may be configured so that they can be worn against the ear (e.g., the cymba of the ear) to deliver TES. Also described herein are methods of using them to modulate a subject's cognitive state. These TES applicators may also be adapted to function as audio headphones for concurrent delivery of TES and audible signals (e.g., music).

The present disclosure relates to devices and methods for stimulating peripheral nerves in a patient via electrical, optical, mechanical, or other stimulation, in order to change the balance between parasympathetic and sympathetic activity by selectively increasing or decreasing each of parasympathetic and sympathetic activity. In a particular application, the present disclosure relates to a device for transdermal stimulation of the vagus nerve (including the auricular branch) to selectively affect the sympathetic and parasympathetic nervous system to achieve the desired therapeutic effect ina human subject.